Home
Conditions
Hypersensitivity, Immediate

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,714 public trials 622 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Enrolling by Invitation

Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)

NCT06603935

Conditions: Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +11 more
Locations: QHSLab West Palm Beach, Florida, United States

View Trial Details

Enrolling by Invitation

CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness

NCT04504955

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: CorEvitas, LLC Waltham, Massachusetts, United States

View Trial Details

Enrolling by Invitation

Thera-Clean® Microbubbles System in Patients With Skin Diseases

NCT07050810

Conditions: Atopic Dermatitis, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations: Northwestern University Department of Dermatology Chicago, Illinois, United States

View Trial Details

Enrolling by Invitation

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

NCT05443321

Conditions: Arrhythmias, Cardiac, Arrythmia, Asthma, +39 more
Locations: Brigham & Women's Hospital Boston, Massachusetts, United States

View Trial Details

Enrolling by Invitation

Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA

NCT07343661

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Autoimmune Diseases, +28 more
Locations: Policlinico Duilio Casula AOU Cagliari Cagliari, Italy

View Trial Details

Enrolling by Invitation

Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies

NCT04933721

Conditions: Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +15 more
Locations: Study Center Ottawa, Canada

Study Center Brno, Czechia

Study Center Pilsen, Czechia

Study Center Grenoble, France

View all 16 locations

View Trial Details

Enrolling by Invitation

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

NCT06262399

Conditions: Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations: Campbelltown Hospital Campbelltown, New South Wales, Australia

Centre National de Reference - Grenoble Grenoble, France

Hôpital Claude Huriez Lille, France

Charite-Universitätsmedizin Berlin Berlin, Germany

View Trial Details

Enrolling by Invitation

Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis

NCT07228325

Conditions: Allergy, Anaphylaxis, Hypersensitivity, +2 more
Locations: Pharma Medica Research Inc Mississauga, Canada

View Trial Details

Enrolling by Invitation

Molecular Basis of Food Allergy

NCT01832324

Conditions: Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +12 more
Locations: The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Enrolling by Invitation

A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis.

NCT07180511

Conditions: Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: EnitiateBioPharma Hangzhou, Zhejiang, China

View Trial Details

Hypersensitivity, Immediate

Hypersensitivity, Immediate trial results

Related conditions